Sommer Ray's Wellness Brand, Imaraïs Beauty, Launches Nationwide at Target
The best-selling plant-based wellness brand expands its reach to Target locations nationwide
Integrating the latest developments and ingredients in beauty, plant-based nutrition, and functional foods, Imaraïs Beauty has created a revolutionary approach to beauty and wellness, disrupting the industry with a complete range of ingestible beauty gummies which are PETA-certified vegan, cruelty-free, sugar-free, gelatin-free, gluten-free, and clinically proven. The delicious gummies support a range of beauty, health and wellness goals, including GLOW skincare, CLARITY anti-blemish, DE-PUFF anti-bloating, NOURISH haircare, YOUTH anti-aging, and SUTRA sexual wellness.
"The launch of Imaraïs Beauty at Target is a dream come true," says
"At Imaraïs Beauty, our mission has always been to redefine beauty from the inside out, and we couldn't be more excited to bring our ingestible beauty line to Target stores nationwide. This launch allows our products to be more accessible to everyone, and we're thrilled to share our innovative approach with Target's community of beauty and wellness enthusiasts," says
To celebrate the launch, the brand will offer opportunities for customers to connect with the brand through live experiential events and digital content featuring
Imaraïs Beauty retails for
For more information, please contact [email protected].
ABOUT IMARAЇS BEAUTY:
Imaraïs Beauty was founded by media personality
View original content to download multimedia:https://www.prnewswire.com/news-releases/sommer-rays-wellness-brand-imarais-beauty-launches-nationwide-at-target-302365699.html
SOURCE Imaraïs Beauty
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Patterson & O'Neill Partner Chris Manasserian Named a Southern California Commercial Real Estate Visionary by LA Times Studios
- Chrysalis Health and Curaechoice Join Forces to Address Cost and Access Barriers to Mental Health Care
- Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share